These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 18386537

  • 1. Effect of oral contraceptives on risk of cervical cancer.
    Vanakankovit N, Taneepanichskul S.
    J Med Assoc Thai; 2008 Jan; 91(1):7-12. PubMed ID: 18386537
    [Abstract] [Full Text] [Related]

  • 2. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987 Jan; (Spec No):40-1. PubMed ID: 12269054
    [Abstract] [Full Text] [Related]

  • 3. Risk factors of venous thromboembolism (VTE) in Thai reproductive aged female: King Chulalongkorn Memorial Hospital experience.
    Worralurt C, Taneepanichskul S.
    J Med Assoc Thai; 2005 Nov; 88(11):1502-5. PubMed ID: 16471093
    [Abstract] [Full Text] [Related]

  • 4. Oral contraceptives and the risk of death from breast cancer.
    Wingo PA, Austin H, Marchbanks PA, Whiteman MK, Hsia J, Mandel MG, Peterson HB, Ory HW.
    Obstet Gynecol; 2007 Oct; 110(4):793-800. PubMed ID: 17906011
    [Abstract] [Full Text] [Related]

  • 5. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study.
    Singh H, Demers AA, Nugent Z, Mahmud SM, Kliewer EV, Bernstein CN.
    Gastroenterology; 2009 Feb; 136(2):451-8. PubMed ID: 18996382
    [Abstract] [Full Text] [Related]

  • 6. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT.
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [Abstract] [Full Text] [Related]

  • 7. [Risk factors for cervico-uterine cancer in women in Zacatecas].
    Castañeda-Iñiguez MS, Toledo-Cisneros R, Aguilera-Delgadillo M.
    Salud Publica Mex; 1998 Sep; 40(4):330-8. PubMed ID: 9774902
    [Abstract] [Full Text] [Related]

  • 8. Risk of breast cancer associated with short-term use of oral contraceptives.
    Folger SG, Marchbanks PA, McDonald JA, Bernstein L, Ursin G, Berlin JA, Daling JR, Norman SA, Strom BL, Weiss LK, Simon MS, Burkman RT, Malone KE, Spirtas R.
    Cancer Causes Control; 2007 Mar; 18(2):189-98. PubMed ID: 17216547
    [Abstract] [Full Text] [Related]

  • 9. Contraception and the big "C".
    Chandran R.
    Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
    [Abstract] [Full Text] [Related]

  • 10. Oral contraceptive use and BRCA penetrance: a case-only study.
    Pasanisi P, Hédelin G, Berrino J, Chang-Claude J, Hermann S, Steel M, Haites N, Hart J, Peled R, Gafà L, Leggio L, Traina A, Amodio R, Primic-Zakelj M, Zadnik V, Veidebaum T, Tekkel M, Berrino F.
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
    [Abstract] [Full Text] [Related]

  • 11. Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.
    Silfverdal L, Kemetli L, Andrae B, Sparén P, Ryd W, Dillner J, Strander B, Törnberg S.
    Am J Obstet Gynecol; 2009 Aug; 201(2):188.e1-7. PubMed ID: 19560117
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for in situ cervical cancer: results from a case-control study.
    Jones CJ, Brinton LA, Hamman RF, Stolley PD, Lehman HF, Levine RS, Mallin K.
    Cancer Res; 1990 Jun 15; 50(12):3657-62. PubMed ID: 2340514
    [Abstract] [Full Text] [Related]

  • 13. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 14. [Oral contraceptives and cancer].
    Ludwig H.
    Schweiz Rundsch Med Prax; 1989 Nov 14; 78(46):1273-5. PubMed ID: 2814116
    [Abstract] [Full Text] [Related]

  • 15. Cigarette smoking and risk of cerebral sinus thrombosis in oral contraceptive users: a case-control study.
    Ciccone A, Gatti A, Melis M, Cossu G, Boncoraglio G, Carriero MR, Iurlaro S, Agostoni E.
    Neurol Sci; 2005 Dec 14; 26(5):319-23. PubMed ID: 16388365
    [Abstract] [Full Text] [Related]

  • 16. Case control study finds long-term pill use is associated with higher risk of benign liver tumors.
    Int Fam Plann Dig; 1976 Jun 14; 2(2):13-5. PubMed ID: 12334249
    [Abstract] [Full Text] [Related]

  • 17. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B, Morrell S, Zuo Y, Roder D, Tracey E, Jelfs P.
    Cancer Causes Control; 2008 Aug 14; 19(6):569-76. PubMed ID: 18286380
    [Abstract] [Full Text] [Related]

  • 18. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.
    Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Moorman PG, Kaufman JS, Cai J, Porter PL, Brinton LA, Eley JW, Coates RJ.
    Cancer Epidemiol Biomarkers Prev; 2007 Sep 14; 16(9):1822-7. PubMed ID: 17855700
    [Abstract] [Full Text] [Related]

  • 19. Risk factors of breast cancer in women in Kelantan, Malaysia.
    Norsa'adah B, Rusli BN, Imran AK, Naing I, Winn T.
    Singapore Med J; 2005 Dec 14; 46(12):698-705. PubMed ID: 16308643
    [Abstract] [Full Text] [Related]

  • 20. [Use of oral contraceptives and increased risk of cervical cancer].
    Schmeink CE, Lenselink CH, Bekkers RL.
    Ned Tijdschr Geneeskd; 2008 Aug 02; 152(31):1717-8. PubMed ID: 18727601
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.